Pheno.AI
Phenotype Multi-omics Datasets to Improve Human Health
Company Overview
Snapshot
Founded in March 2021 by Ori Cohen, Pheno.AI operates with 11–50 employees. The company has secured funding across two rounds from Entrée Capital and Corundum Neuroscience, with Entrée Capital leading a Seed round in June 2022. In November 2024, Pheno.AI further strengthened its position by developing a glucose monitoring model in collaboration with Nvidia and the Weizmann Institute.
Business overview
Pheno.AI is dedicated to advancing human health by curating and providing access to extensive deep-phenotype multi-omics datasets. The company's core technology involves organizing and making accessible data collected as part of the Human Phenotype Project, a 25-year longitudinal study that has enrolled 20,000 participants. Pheno.AI offers a secure, compliant workspace with adjustable compute resources, enabling collaborative research. It serves the Health Tech & Life Sciences sector, with a focus on digital healthcare, medical decision support, and applications in biotechnology, pharmaceuticals, laboratories, and healthcare providers.
Strategic signal
In November 2024, Pheno.AI collaborated with Nvidia and the Weizmann Institute to develop a glucose monitoring model. This partnership signifies a strong validation of Pheno.AI's data and research capabilities, demonstrating its potential to contribute to advanced medical solutions and attract high-profile collaborations in the health tech and life sciences industry.
Company Intelligence Q&A
- When was Pheno.AI founded and by whom?
- Pheno.AI was founded in March 2021 by Ori Cohen.
- What is Pheno.AI's primary mission?
- Pheno.AI's mission is to improve human health by collecting, organizing, and making accessible the world's largest collection of deep-phenotype multi-omics datasets, and by enabling others to do the same.
- Which investors have participated in Pheno.AI's funding rounds?
- Pheno.AI has received funding from Entrée Capital and Corundum Neuroscience. Entrée Capital led a Seed round in June 2022.
- What significant collaboration did Pheno.AI announce in November 2024?
- In November 2024, Pheno.AI, in collaboration with Nvidia and the Weizmann Institute, developed a glucose monitoring model.
- What kind of data does Pheno.AI provide access to?
- Pheno.AI provides access to deep-phenotype multi-omics datasets collected as part of the Human Phenotype Project, a 25-year longitudinal study that has enrolled 20,000 participants.